Mobile Stress Management Program for African American Women

Status Recruiting

Clinical Trial Summary

The unjust social, economic, and environmental conditions that African Americans face throughout their lives lead to pervasive health disparities. These disparities are driven by healthcare differences. They are driven by economic differences. Those with less financial wealth have poorer health as compared to those with higher socioeconomic status. And yet, even when controlling for these two important social determinants of health, race still predicts morbidity and mortality. What can account for this? Stress. African Americans experience more stress than their White peers. The story is even more dire for African American women who simultaneously face both racial discrimination and sexism. Indeed, gendered racial discrimination is nearly ubiquitous for Black women at all socioeconomic levels. It is also a distinct form of stress, with unique outcomes compared to other non-race-or-gender-related stressors. Finally, stress has clear downstream negative effects on health. At present, there is no mobile cognitive-behavioral stress management intervention (m-CBSMi) designed to help African American women manage racial and nonracial daily stress. The investigators intend to fill this void. Using proven CBSMi techniques, participants will learn how to manage their stress through text messages and integrated mobile web content. Supportive texts will inspire, motivate, and affirm the life experiences of participants. Educational texts will increase knowledge, develop skills, and reduce barriers to adaptive coping. A library of individually tailored videos will be delivered to each participant. All mobile web content will be accessible only through touch-based links embedded within text messages, making it easy and effortless to view this material. During Phase II the investigators will complete development of the m-CBSMi. Then, the investigators will examine the effectiveness of the m-CBSMi to reduce stress among African American female participants. Participants will be randomly assigned to either the intervention condition or to a matched control condition. Secondary measures will assess coping, well-being, subjective health, gendered racial identity, and knowledge.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04863781
Study type	Interventional
Source	ISA Associates, Inc.
Contact	Douglas Billings, PhD
Phone	7037390880
Email	dbillings@isagroup.com
Status	Recruiting
Phase	N/A
Start date	March 31, 2023
Completion date	May 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04680611` - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed	`NCT05703087` - Positive Cueing in Knee Arthroplasty.	N/A
Completed	`NCT02629016` - Stress Reduction: A Pilot Study With Adolescents	N/A
Completed	`NCT02541240` - Effects of an Intervention to Enhance Resilience in Physical Therapy Students	N/A
Completed	`NCT01406028` - Does Emotional Support Decrease In Vitro Fertilization Stress?	N/A
Completed	`NCT00121160` - Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response	Phase 1
Completed	`NCT02621775` - Effectiveness of Two Stress Management Programs in Adaptation Disorder With Anxiety (ADA)	N/A
Recruiting	`NCT04474418` - Psychometric Characterization of Patients With Cardiac Arrhythmias
Completed	`NCT03310112` - Mindfulness Training in U.S. Army Cohorts	N/A
Terminated	`NCT03893617` - Brief Stresses Experimental Study	Phase 1
Active, not recruiting	`NCT05542498` - Promoting Stress Management and Engagement in Introductory Physics Courses With Mindfulness and Relaxation	N/A
Completed	`NCT02394899` - Improving Parental Psychosocial Functioning and Early Developmental Outcomes in Children With Sickle Cell Disease	N/A
Terminated	`NCT00962273` - The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak	N/A
Completed	`NCT00451126` - Moderating Impact of Various Emotion Personality Factors on Salivary Cortisol Response to a TSST	N/A
Completed	`NCT06051500` - Psychological and Physiological Effects of Different Objects of Breath Meditation	N/A
Completed	`NCT02801045` - Art Therapy in Palliative Care: Study of Identification and Understanding of the Mechanisms of Change in the Patient	N/A
Completed	`NCT03308344` - Mindfulness Training in Military Spouses	N/A
Recruiting	`NCT06029348` - Cerebrovascular Health and Resilience in Midlife	N/A
Completed	`NCT05869006` - The Effect of Designed SIA Instrument Supported Interpersonal Relations-Based Group Practice on Psychological Well-Being and Creativity	N/A
Completed	`NCT04484649` - Sleeping Healthy/Living Healthy Development	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.